InvestorInvesting in the future of life sciences and technology.

MeOhr Ventures is an early-stage venture capital fund based in Haifa, Israel, focused on life sciences, particularly in catalyzing cures for high-mortality diseases. The fund operates with a high-conviction, concentrated portfolio strategy.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
MeOhr Ventures is an early-stage venture capital fund located in Haifa, Israel, dedicated to investing in life sciences sectors such as biotech, medtech, digital health, and healthcare IT. The organization aims to catalyze world-changing cures for globally significant, high-mortality diseases. Although currently limited in public information, MeOhr Ventures operates with a high-conviction, concentrated portfolio strategy, focusing on early-stage opportunities. The fund is listed on various Israeli VC directories, indicating its legitimacy within the venture capital ecosystem.
MeOhr Ventures focuses on early-stage investments in the life sciences sector, targeting innovative solutions in biotech, medtech, digital health, and healthcare IT. The firm seeks to build a concentrated portfolio of high-conviction investments that can lead to significant advancements in healthcare.
MeOhr Ventures aims to add value by supporting portfolio companies in their mission to develop groundbreaking solutions for high-mortality diseases, leveraging its expertise in the life sciences sector.
MeOhr Ventures focuses on early-stage investments in the life sciences sector, particularly in biotech, medtech, digital health, and healthcare IT. The firm seeks innovative solutions that address high-mortality diseases.
While specific application procedures are not disclosed, MeOhr Ventures is open to engaging with startups at any stage of development. Founders are encouraged to reach out directly to the firm for potential discussions.
MeOhr Ventures emphasizes a concentrated portfolio strategy, focusing on high-conviction investments that target significant health challenges. This approach allows for deeper engagement with portfolio companies.
The firm is based in Haifa, Israel, and primarily focuses on the Israeli life sciences sector, although it may consider opportunities globally.
Details regarding the fund size or specific check sizes have not been publicly disclosed. However, the firm is known for its concentrated investment strategy.
MeOhr Ventures aims to add value by supporting portfolio companies in their mission to develop groundbreaking solutions for high-mortality diseases, leveraging its expertise in the life sciences sector.
Superscout Pro
Is this page right?Reviewed · How the research works